|Bid||0.0000 x 800|
|Ask||0.0000 x 900|
|Day's range||3.0004 - 3.0900|
|52-week range||0.7255 - 6.6000|
|Beta (5Y monthly)||1.37|
|PE ratio (TTM)||N/A|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
We often see insiders buying up shares in companies that perform well over the long term. Unfortunately, there are also...
RedHill (RDHL) gets Orphan Drug status from the FDA for the treatment of nontuberculous mycobacteria (NTM) disease.